18F-DCFPyL PSMA PET/CT for Lu-177 eligibility evaluation
The 18F-DCFPyL PSMA scan is potentially superior to the Ga68-PSMA scan and we have been accepted into a trial using this scan at no cost.
My question is, is the 18F-DCFPyL PSMA scan readily accepted in Germany as proof of PSMA avidity for potential LU-177 treatment or is it better to get a Ga68 PSMA since that is what the doctors are used to evaluating?
I can't say how much this site has helped us, I am so grateful to all of you who share, learn, and are of service here.
Just curious which trial. I did a trial through Johns Hopkins (Dr. Ken Pienta) in 2017 with the 18-FDCFPyL. They were very good.
All the best.
I called them about this trial:
clinicaltrials.gov/ct2/show...
but was referred to what I assume is this trial:
clinicaltrials.gov/ct2/show...
It says it is closed, but the recruitment coordinator told me they had reoppened it. We were only offered the 68GA-RM2 through the first trial link above, which is not PSMA bound.
PSMA PET required for LU PSMA therapy?
Update after LU 177 PSMA
Lu-177-PSMA First Infusion 
It makes no difference. Both scans are readily accepted in Germany as proof of PSMA avidity. Some clinics use 18F-DCFPyL, some Ga68, some both.
Thank you, I didn't realize that both were used in Germany. We will probably move forward with the 18F-DCFPyL PSMA.